ranimustine has been researched along with Glioma in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (28.57) | 18.7374 |
| 1990's | 11 (52.38) | 18.2507 |
| 2000's | 3 (14.29) | 29.6817 |
| 2010's | 1 (4.76) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ikuta, S; Maruyama, T; Muragaki, Y; Nitta, M | 1 |
| Fujii, M; Ito, M; Natsume, A; Ohno, M; Wakabayashi, T | 1 |
| Inoue, I; Kageyama, N; Kito, A; Kobayashi, T; Wakabayashi, T; Yoshida, J | 1 |
| Harada, K; Kiya, K; Okamoto, H; Uozumi, T | 1 |
| Inoue, I; Kageyama, N; Kanzaki, M; Nagata, M; Wakabayashi, T; Yoshida, J | 1 |
| Akiyama, Y; Fukuda, M; Kagawa, T; Kimura, Y; Konishi, S; Moritake, K; Nagao, S; Yamasaki, T | 1 |
| Fujita, H; Hotta, T; Ikenaga, M; Ishizaki, K; Isowa, G; Kiya, K; Kurisu, K; Mikami, T; Saito, Y; Uozumi, T | 1 |
| Hotta, T; Ikenaga, M; Ishizaki, K; Isowa, G; Kiya, K; Kurisu, K; Mikami, T; Saito, Y; Uozumi, T | 1 |
| Furuta, T; Higashi, H; Maeshiro, T; Matsumoto, K; Nakagawa, M; Ohmoto, T; Ono, Y; Shinohara, C; Tamiya, T; Tsuno, K | 1 |
| Hodozuka, A; Nakai, H; Sako, K; Suzuki, N; Tomabechi, M; Yonemasu, Y | 1 |
| Furuta, T; Hiraki, Y; Matsumoto, K; Nakagawa, T; Ohmoto, T; Tada, E | 1 |
| Furuta, T; Maeda, Y; Matsumoto, K; Mizumatsu, S; Ohmoto, T; Tamiya, T | 1 |
| Hatano, N; Kajita, Y; Mizuno, M; Nakayashiki, N; Ohno, T; Takemura, A; Wakabayashi, T; Yoshida, J | 1 |
| Hatano, N; Kajita, Y; Mizuno, M; Nagasaka, T; Ohno, T; Taniguchi, K; Wakabayashi, T; Yoshida, J; Yoshida, T | 1 |
| Miyagami, M; Tazoe, M; Tsubokawa, T | 1 |
| Kraemer, HP; Schönmayr, R; Tonn, JC | 1 |
| Shoin, K; Yamashima, T; Yamashita, J | 1 |
| Goishi, A; Inagawa, T; Kajikawa, H; Kawashima, K; Kitaoka, T; Kiya, K; Kodama, Y; Kurisu, K; Ohta, M; Uozumi, T | 1 |
| Fujioka, Y; Goishi, A; Harada, K; Inagawa, T; Kitaoka, T; Kiya, K; Okamoto, H; Sasaki, U; Shima, T; Uozumi, T | 1 |
| Fushimi, S; Itoh, Y; Kowada, M; Mineura, K | 1 |
| Fushimi, S; Ishino, Y; Kowada, M; Mineura, K; Sasajima, H; Sasaki, J | 1 |
5 trial(s) available for ranimustine and Glioma
| Article | Year |
|---|---|
[Preliminary results of a combination therapy of irradiation, MCNU, carboplatin (CBDCA) and IFN-beta (MCI therapy) for gliomas].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Combined Modality Therapy; Female; Glioma; Humans; Interferon-beta; Male; Middle Aged; Nitrosourea Compounds | 1993 |
Effect of adjuvant iridium-192 brachytherapy on the survival of patients with malignant gliomas.
Topics: Adult; Antineoplastic Agents; Brachytherapy; Combined Modality Therapy; Female; Glioma; Humans; Iridium Radioisotopes; Male; Middle Aged; Nitrosourea Compounds; Radiotherapy, Adjuvant; Supratentorial Neoplasms; Survival Rate | 1997 |
[A clinical evaluation of combination therapy with radiation, MCNU, carboplatin and IFN-beta or with radiation, MCNU, carboplatin, etoposide and IFN-beta for malignant gliomas].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Combined Modality Therapy; Drug Administration Schedule; Etoposide; Female; Glioma; Humans; Interferon-beta; Male; Middle Aged; Nitrosourea Compounds; Prognosis; Survival Rate | 1998 |
[Randomized study of initial treatment with radiation.MCNU or radiation.MCNU.interferon-beta for malignant glioma. Hiroshima Brain Tumor Study Group].
Topics: Adult; Aged; Antineoplastic Agents; Brain Neoplasms; Combined Modality Therapy; Female; Glioma; Humans; Infusions, Intravenous; Injections, Intravenous; Interferon Type I; Male; Middle Aged; Nitrosourea Compounds; Radiotherapy Dosage; Randomized Controlled Trials as Topic | 1990 |
[Clinical trial of MCNU for malignant brain tumors].
Topics: Antineoplastic Agents; Astrocytoma; Brain Neoplasms; Clinical Trials as Topic; Drug Administration Schedule; Glioblastoma; Glioma; Humans; Leukopenia; Nitrosourea Compounds; Radiotherapy Dosage | 1985 |
16 other study(ies) available for ranimustine and Glioma
| Article | Year |
|---|---|
[Nimustine hydrochloride/ranimustine efficacy and safety in glioma].
Topics: Antineoplastic Agents; Brain Neoplasms; Glioma; Humans; Nimustine; Nitrosourea Compounds | 2016 |
Interferon-beta, MCNU, and conventional radiotherapy for pediatric patients with brainstem glioma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Stem Neoplasms; Carboplatin; Child; Child, Preschool; Dacarbazine; Disease-Free Survival; DNA Methylation; Etoposide; Female; Glioma; Humans; Interferon-beta; Magnetic Resonance Imaging; Male; Nitrosourea Compounds; Retrospective Studies; Temozolomide; Treatment Outcome | 2009 |
[Effect of MCNU on brain tumors. Part II: Clinical experience with MCNU on malignant brain tumors].
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Bone Marrow Transplantation; Brain; Brain Neoplasms; Child; Drug Administration Schedule; Female; Glioblastoma; Glioma; Humans; Male; Medulloblastoma; Middle Aged; Nitrosourea Compounds; Tomography, X-Ray Computed | 1984 |
[Comparative studies on anti-tumor effects of nitrosoureas, ACNU and MCNU, on experimental brain tumors (author's transl)].
Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Cell Division; Glioma; Male; Mice; Mice, Inbred C57BL; Neoplasms, Experimental; Nimustine; Nitrosourea Compounds | 1981 |
[MCNU effectiveness on brain tumor. Part I: Antitumor activity in vitro on human glioma and neuroblastoma cell lines].
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cell Line; Cells, Cultured; DNA, Neoplasm; Flow Cytometry; Glioma; Humans; Mitosis; Neuroblastoma; Nimustine; Nitrosourea Compounds | 1984 |
[Intratumoral pharmacokinetics following intraarterial administration of MCNU in patients with malignant gliomas].
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Brain Neoplasms; Female; Glioblastoma; Glioma; Half-Life; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Male; Middle Aged; Nitrosourea Compounds | 1995 |
O6-alkylguanine-DNA alkyltransferase activity of human malignant glioma and its clinical implications.
Topics: Astrocytoma; Brain Neoplasms; Combined Modality Therapy; DNA Damage; DNA Repair; DNA, Neoplasm; Drug Resistance; Enzyme Induction; Glioblastoma; Glioma; Humans; Methyltransferases; Neoplasm Proteins; Neoplasm Recurrence, Local; Nimustine; Nitrosourea Compounds; O(6)-Methylguanine-DNA Methyltransferase; Tetrazolium Salts; Thiazoles | 1994 |
Interrelationship between O6-alkylguanine-DNA alkyltransferase activity and susceptibility to chloroethylnitrosoureas in several glioma cell lines.
Topics: Animals; Drug Resistance; Glioma; Humans; Interferon-beta; Methyltransferases; Nimustine; Nitrosourea Compounds; O(6)-Methylguanine-DNA Methyltransferase; Rats; Tumor Cells, Cultured | 1993 |
Delivery of a novel nitrosourea, MCNU, to the brain tissue in glioma-bearing rats. Intracarotid versus intravenous infusion.
Topics: Animals; Blood-Brain Barrier; Brain Neoplasms; Carotid Artery, External; Carotid Artery, Internal; Glioma; Infusions, Intra-Arterial; Infusions, Intravenous; Male; Nitrosourea Compounds; Rats; Rats, Wistar | 1993 |
Efficacy of post operative adjuvant therapy with human interferon beta, MCNU and radiation (IMR) for malignant glioma: comparison among three protocols.
Topics: Adjuvants, Immunologic; Adolescent; Adult; Aged; Antineoplastic Agents; Child; Child, Preschool; Combined Modality Therapy; Female; Glioma; Humans; Interferon-beta; Male; Middle Aged; Nitrosourea Compounds; Postoperative Care; Radiotherapy; Survival Analysis | 2000 |
Initial and maintenance combination treatment with interferon-beta, MCNU (Ranimustine), and radiotherapy for patients with previously untreated malignant glioma.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Female; Glioma; Humans; Interferon-beta; Male; Middle Aged; Nitrosourea Compounds; Survival Analysis; Tomography, X-Ray Computed; Treatment Outcome | 2000 |
[MCNU delivery into malignant brain tumor and normal brain tissue by intravenous or intraarterial infusion].
Topics: Animals; Antineoplastic Agents; Brain; Brain Neoplasms; Glioblastoma; Glioma; Humans; Infusions, Intra-Arterial; Infusions, Intravenous; Male; Nitrosourea Compounds; Rats; Rats, Inbred F344 | 1990 |
Sensitivity of human malignant intracranial tumors against MCNU in vitro in comparison to ACNU and BCNU.
Topics: Aged; Antineoplastic Agents; Astrocytoma; Brain Neoplasms; Carmustine; Drug Screening Assays, Antitumor; Female; Glioma; Humans; Male; Middle Aged; Nimustine; Nitrosourea Compounds; Tumor Cells, Cultured | 1990 |
Neurotoxicity of local administration of two nitrosoureas in malignant gliomas.
Topics: Adolescent; Adult; Aged; Brain Neoplasms; Dose-Response Relationship, Drug; Female; Glioma; Humans; Male; Middle Aged; Neurotoxins; Nimustine; Nitrosourea Compounds | 1990 |
DNA lability induced by nimustine and ramustine in rat glioma cells.
Topics: Animals; Antineoplastic Agents; Base Sequence; Brain Neoplasms; Cell Line; DNA Damage; DNA, Neoplasm; Dose-Response Relationship, Drug; Glioma; Nimustine; Nitrosourea Compounds; Rats; Tumor Cells, Cultured | 1988 |
[Analysis of DNA damage induced by nitrosourea derivatives in rat brain tumor cells using a sequencing procedure].
Topics: Animals; Antineoplastic Agents; Base Sequence; Brain Neoplasms; DNA Damage; DNA, Neoplasm; DNA, Satellite; Glioma; Nimustine; Nitrosourea Compounds; Rats | 1988 |